Redox Imbalance and Pulmonary Function in Bleomycin-Induced Fibrosis in C57BL/6, DBA/2, and BALB/c Mice

Toxicologic Pathology

Volumn 40, Issue 5, 2012, Pages 731-741

  Santos Silva, Marco Aurélio ^a   Pires, Karla Maria Pereira ^a   Trajano, Eduardo Tavares Lima ^a   Martins, Vanessa ^b   Nesi, Renata Tiscoski ^b   Benjamin, Cláudia Farias ^b   Caetano, Maurício Silva ^c   Sternberg, Cinthya ^c   Machado, Mariana Nascimento ^b   Zin, Walter Araújo ^b   Valença, Samuel Santos ^b   Porto, Luis Cristóvão ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

mouse strains; pulmonary fibrosis; pulmonary function; redox imbalance

Indexed keywords

BLEOMYCIN; PROLINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; MALE; MOLECULAR INTERACTION; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDOX IMBALANCE; REDOX STRESS; VISCOELASTICITY;

ANIMALS; BLEOMYCIN; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PULMONARY FIBROSIS; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SUPEROXIDE DISMUTASE;

EID: 84862737130     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312441404     Document Type: Article

References (68)

1. Abid S. H. Malhotra V. Perry M. C. (2001). Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13, 242–8.
2. Aebi H. (1984). Catalase in vitro. Methods Enzymol 105, 121–6.
3. Amara N. Goven D. Prost F. Muloway R. Crestani B. Boczkowski J. (2010). NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65, 733–8.
4. Aoyagi-Ikeda K. Maeno T. Matsui H. Ueno M. Hara K. Aoki Y. Aoki F. Shimizu T. Doi H. Kawai-Kowase K. Iso T. Suga T. Arai M. Kurabayashi M. (2010). Notch induces myofibroblast differentiation of alveolar epithelial cells via TGF-ss/Smad3 pathway. Am J Respir Cell Mol Biol 45, 136–44.
5. Bannister J. V. Calabrese L. (1987). Assays for superoxide dismutase. Methods Biochem Anal 32, 279–312.
6. Bradford M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–54.
7. Cardoso J. F. Mendes F. A. Amadeu T. P. Romana-Souza B. Valenca S. S. Porto L. C. Abreu J. G. Monte-Alto-Costa A. (2009). Ccn2/Ctgf overexpression induced by cigarette smoke during cutaneous wound healing is strain dependent. Toxicol Pathol 37, 175–82.
8. Cardoso J. F. Souza B. R. Amadeu T. P. Valenca S. S. Porto L. C. Costa A. M. (2007). Effects of cigarette smoke in mice wound healing is strain dependent. Toxicol Pathol 35, 890–6.
9. Chen J. Stubbe J. (2005). Bleomycins: Towards better therapeutics. Nat Rev Cancer 5, 102–12.
10. Chung M. P. Monick M. M. Hamzeh N. Y. Butler N. S. Powers L. S. Hunninghake G. W. (2003). Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol 29, 375–80.
11. Cottin V. Cordier J. F. (2008). Idiopathic pulmonary fibrosis. Presse Med 37, 1581–90.
12. Day B. J. (2008). Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 10, 355–70.
13. De Raeve H. R. Thunnissen F. B. Kaneko F. T. Guo F. H. Lewis M. Kavuru M. S. Secic M. Thomassen M. J. Erzurum S. C. (1997). Decreased Cu, Zn-SOD activity in asthmatic airway epithelium: Correction by inhaled corticosteroid in vivo. Am J Physiol 272, L148–54.
14. Draper H. H. Squires E. J. Mahmoodi H. Wu J. Agarwal S. Hadley M. (1993). A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 15, 353–63.
15. Driscoll K. E. Maurer J. K. Lindenschmidt R. C. Romberger D. Rennard S. I. Crosby L. (1990). Respiratory tract responses to dust: Relationships between dust burden, lung injury, alveolar macrophage fibronectin release, and the development of pulmonary fibrosis. Toxicol Appl Pharmacol 106, 88–101.
16. du Bois R. M. (2002). The genetic predisposition to interstitial lung disease: Functional relevance. Chest 121, 14S–20S.
17. Dweik R. A. (2005). Nitric oxide, hypoxia, and superoxide: the good, the bad, and the ugly! Thorax 60, 265–7.
18. Faffe D. S. Zin W. A. (2009). Lung parenchymal mechanics in health and disease. Physiol Rev 89, 759–75.
19. Fattman C. L. Chang L. Y. Termin T. A. Petersen L. Enghild J. J. Oury T. D. (2003). Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med 35, 763–71.
20. Fernandez Perez E. R. Daniels C. E. Schroeder D. R. St Sauver J. Hartman T. E. Bartholmai B. J. Yi E. S. Ryu J. H. (2010). Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest 137, 129–37.
21. Flohe L. Gunzler W. A. (1984). Assays of glutathione peroxidase. Methods Enzymol 105, 114–21.
22. Fyfe A. J. McKay P. (2010). Toxicities associated with bleomycin. J R Coll Physicians Edinb 40, 213–5.
23. Garcia C. K. (2011). Idiopathic pulmonary fibrosis: Update on genetic discoveries. Proc Am Thorac Soc 8, 158–62.
24. Garcia-Prieto E. Gonzalez-Lopez A. Cabrera S. Astudillo A. Gutierrez-Fernandez A. Fanjul-Fernandez M. Batalla-Solis E. Puente X. S. Fueyo A. Lopez-Otin C. Albaiceta G. M. (2010). Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One 5, e13242.
25. Harrison J. H. Jr. Lazo J. S. (1987). High dose continuous infusion of bleomycin in mice: A new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther 243, 1185–94.
26. Hecker L. Vittal R. Jones T. Jagirdar R. Luckhardt T. R. Horowitz J. C. Pennathur S. Martinez F. J. Thannickal V. J. (2009). NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15, 1077–81.
27. Higashiyama H. Yoshimoto D. Kaise T. Matsubara S. Fujiwara M. Kikkawa H. Asano S. Kinoshita M. (2007). Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 83, 39–46.
28. Homer R. J. Elias J. A. Lee C. G. Herzog E. (2011). Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med 135, 780–8.
29. Iraz M. Erdogan H. Kotuk M. Yagmurca M. Kilic T. Ermis H. Fadillioglu E. Yildirim Z. (2006). Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacol Res 53, 310–6.
30. Jones A. W. (1978). Bleomycin lung damage: The pathology and nature of the lesion. Br J Dis Chest 72, 321–6.
31. Kaarteenaho-Wiik R. Kinnula V. L. (2004). Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. J Histochem Cytochem 52, 1231–40.
32. Kalayarasan S. Sriram N. Sudhandiran G. (2008). Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta. Life Sci 82, 1142–53.
33. Kasper M. Barth K. (2009). Bleomycin and its role in inducing apoptosis and senescence in lung cells—modulating effects of caveolin-1. Curr Cancer Drug Targets 9, 341–53.
34. Keller D. A. Menzel D. B. (1989). Effects of sulfite on glutathione S-sulfonate and the glutathione status of lung cells. Chem Biol Interact 70, 145–56.
35. Kikuchi N. Ishii Y. Morishima Y. Yageta Y. Haraguchi N. Itoh K. Yamamoto M. Hizawa N. (2010). Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 11, 31.
36. Kikuchi N. Ishii Y. Morishima Y. Yageta Y. Haraguchi N. Yamadori T. Masuko H. Sakamoto T. Yanagawa T. Warabi E. Ishii T. Hizawa N. (2011). Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I. Am J Respir Cell Mol Biol 45, 600–9.
37. Kim J. H. Kim H. Y. Kim S. Chung J. H. Park W. S. Chung D. H. (2005). Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am J Pathol 167, 1231–41.
38. Kliment C. R. Oury T. D. (2010). Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radic Biol Med 49, 707–17.
39. Konigshoff M. Kramer M. Balsara N. Wilhelm J. Amarie O. V. Jahn A. Rose F. Fink L. Seeger W. Schaefer L. Gunther A. Eickelberg O. (2009). WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 119, 772–87.
40. Lamy M. L. Fallat R. J. Koeniger E. L. Dietrich H. P. Kamm B. Hill J. D. (1975). Pathophysiology of adult respiratory distress syndrome. Acta Anaesthesiol Belg 23 (Suppl.), 64–77.
41. Lemay A. M. Haston C. K. (2005). Bleomycin-induced pulmonary fibrosis susceptibility genes in AcB/BcA recombinant congenic mice. Physiol Genomics 23, 54–61.
42. Manoury B. Caulet-Maugendre S. Guenon I. Lagente V. Boichot E. (2006). TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int J Immunopathol Pharmacol 19, 471–87.
43. Manoury B. Nenan S. Guenon I. Boichot E. Planquois J. M. Bertrand C. P. Lagente V. (2006). Macrophage metalloelastase (MMP-12) deficiency does not alter bleomycin-induced pulmonary fibrosis in mice. J Inflamm (Lond) 3, 2.
44. Martins V. Valenca S. S. Farias-Filho F. A. Molinaro R. Simoes R. L. Ferreira T. P. Silva P. M. Hogaboam C. M. Kunkel S. L. Fierro I. M. Canetti C. Benjamim C. F. (2009). ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. J Immunol 182, 5374–81.
45. Meister A. Anderson M. E. (1983). Glutathione. Annu Rev Biochem 52, 711–60.
46. Meneghin A. Hogaboam C. M. (2007). Infectious disease, the innate immune response, and fibrosis. J Clin Invest 117, 530–8.
47. Moeller A. Ask K. Warburton D. Gauldie J. Kolb M. (2008). The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40, 362–82.
48. Moore B. B. Hogaboam C. M. (2008). Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294, L152–60.
49. Muller W. E. Zahn R. K. (1977). Bleomycin, an antibiotic that removes thymine from double-stranded DNA. Prog Nucleic Acid Res Mol Biol 20, 21–57.
50. Odajima N. Betsuyaku T. Nagai K. Moriyama C. Wang D. H. Takigawa T. Ogino K. Nishimura M. (2010). The role of catalase in pulmonary fibrosis. Respir Res 11, 183.
51. Pardo A. Selman M. (2002). Molecular mechanisms of pulmonary fibrosis. Front Biosci 7, d1743–61.
52. Phan S. H. (2002). The myofibroblast in pulmonary fibrosis. Chest 122, 286S–9S.
53. Raghu G. Weycker D. Edelsberg J. Bradford W. Z. Oster G. (2006). Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174, 810–6.
54. Rahman I. Kilty I. (2006). Antioxidant therapeutic targets in COPD. Curr Drug Targets 7, 707–20.
55. Rahman I. MacNee W. (1996). Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med 21, 669–81.
56. Rueff-Barroso C. R. Trajano E. T. Alves J. N. Paiva R. O. Lanzetti M. Pires K. M. Bezerra F. S. Pinho R. A. Valenca S. S. Porto L. C. (2010). Organ-related cigarette smoke-induced oxidative stress is strain-dependent. Med Sci Monit 16, BR218–26.
57. Russo R. C. Garcia C. C. Barcelos L. S. Rachid M. A. Guabiraba R. Roffe E. Souza A. L. Sousa L. P. Mirolo M. Doni A. Cassali G. D. Pinho V. Locati M. Teixeira M. M. (2010). Phosphoinositide 3-kinase gamma plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. J Leukoc Biol 89, 269–82.
58. Russo R. C. Garcia C. C. Barcelos L. S. Rachid M. A. Guabiraba R. Roffe E. Souza A. L. Sousa L. P. Mirolo M. Doni A. Cassali G. D. Pinho V. Locati M. Teixeira M. M. (2011). Phosphoinositide 3-kinase gamma plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. J Leukoc Biol 89, 269–82.
59. Sato K. Tashiro Y. Chibana S. Yamashita A. Karakawa T. Kohrogi H. (2008). Role of lipid-derived free radical in bleomycin-induced lung injury in mice: Availability for ESR spin trap method with organic phase extraction. Biol Pharm Bull 31, 1855–9.
60. Segel M. J. Izbicki G. Cohen P. Y. Or R. Christensen T. G. Wallach-Dayan S. B. Breuer R. (2003). Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis. Am J Physiol Lung Cell Mol Physiol 285, L1255–62.
61. Strieter R. M. (2008). What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc Am Thorac Soc 5, 305–10.
62. Tanaka K. Ishihara T. Azuma A. Kudoh S. Ebina M. Nukiwa T. Sugiyama Y. Tasaka Y. Namba T. Sato K. Mizushima Y. Mizushima T. (2010). Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 298, L348–60.
63. Valenca S. S. Pimenta W. A. Rueff-Barroso C. R. Ferreira T. S. Resende A. C. Moura R. S. Porto L. C. (2009). Involvement of nitric oxide in acute lung inflammation induced by cigarette smoke in the mouse. Nitric Oxide 20, 175–81.
64. Vlahovic G. Russell M. L. Mercer R. R. Crapo J. D. (1999). Cellular and connective tissue changes in alveolar septal walls in emphysema. Am J Respir Crit Care Med 160, 2086–92.
65. Weibel E. R. Hsia C. C. Ochs M. (2007). How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 102, 459–67.
66. Woessner J. F., Jr. (1961). The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93, 440–7.
67. Zelko I. N. Mariani T. J. Folz R. J. (2002). Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33, 337–49.
68. Ziesche R. Hofbauer E. Wittmann K. Petkov V. Block L. H. (1999). A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 341, 1264–9.